New Phase III data for AstraZeneca's gout drug lesinurad have backed its efficacy and seem to address earlier concerns about its safety. Last year, AZ reported the results of the Phase III LIGHT ...

Gout is a form of inflammatory arthritis that causes severe pain and swelling in one or more of your joints. These attacks happen suddenly when there's a buildup of uric acid, a chemical found ...

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a ...

The Company has prepared a broad Type B meeting review at the request of the FDA, including review of chemistry, manufacturing, pharmacology, toxicology and clinical evidence regarding the Company’s ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX ...

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout "We are excited and very pleased with the outcome of our Phase 2b clinical study in ...